A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
Latest Information Update: 03 Nov 2023
At a glance
- Drugs Etrumadenant (Primary) ; Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Zimberelimab (Primary)
- Indications Adenocarcinoma; Rectal cancer
- Focus Therapeutic Use
- Acronyms PANTHER
- 10 Apr 2022 Status changed from not yet recruiting to recruiting.
- 02 Mar 2022 Planned initiation date changed from 1 Dec 2021 to 14 Mar 2022.
- 02 Sep 2021 New trial record